RxDoctor Payments Data

Jose de Cardenas, MD

Pulmonary Disease · Ann Arbor, MINPI 1275806408

Payments from drug & device makers

What this record shows

This record is dominated by education: $79,000 of the $115,469 with a category attached, or 68.4%. Intuitive Surgical accounts for 80.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $56,478 and has fallen 59.3% since, to $22,999 in 2025. Among pulmonary disease clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$115,469in general payments, 2019–2025

Across 134 payments — averaging $861.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$93K
  • Medtronic$10K
  • Cook Incorporated$10K
  • Pinnacle Biologics, Inc$2K
  • Pulmonx Corporation$170
  • ERBE USA Inc$117
  • plus $11 from 1 others
$5,965in research payments, 2019–2025

Across 1 payment — averaging $5965.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$6K

What the payments were for

  • Consulting fees$8,1007%
  • Speaking & faculty fees$10,8959%
  • Travel & lodging$12,91311%
  • Food & beverage$4,5614%
  • Education$79,00068%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical98$93,199
Medtronic20$10,374
Cook Incorporated4$9,670
Pinnacle Biologics, Inc8$1,926
Pulmonx Corporation2$170
ERBE USA Inc1$117
Ambu Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$115,469 in reported general payments places this provider in the 95th percentile of 463 pulmonary disease providers in Michigan.

See all pulmonary disease providers in Michigan

Medicare billing

Part B allowed, 2024
$43,492
Medicare patients
147
Services billed
438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$14,198
Spiriva RespimatTiotropium Bromide18$9,148
Stiolto RespimatTiotropium Br/Olodaterol Hcl13$5,915
Incruse ElliptaUmeclidinium Bromide11$3,640
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$1,820
Albuterol Sulfate HfaAlbuterol Sulfate30$1,062
Prednisone15$36

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →